1. Home
  2. CRVS vs MCBS Comparison

CRVS vs MCBS Comparison

Compare CRVS & MCBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

N/A

Current Price

$14.56

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Logo MetroCity Bankshares Inc.

MCBS

MetroCity Bankshares Inc.

N/A

Current Price

$35.13

Market Cap

1.0B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
CRVS
MCBS
Founded
2014
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.0B
IPO Year
2016
2019

Fundamental Metrics

Financial Performance
Metric
CRVS
MCBS
Price
$14.56
$35.13
Analyst Decision
Strong Buy
Hold
Analyst Count
6
1
Target Price
$30.17
$33.00
AVG Volume (30 Days)
757.8K
65.9K
Earning Date
05-07-2026
04-24-2026
Dividend Yield
N/A
3.63%
EPS Growth
48.04
4.76
EPS
N/A
1.53
Revenue
N/A
N/A
Revenue This Year
N/A
$36.78
Revenue Next Year
N/A
$2.44
P/E Ratio
N/A
$23.21
Revenue Growth
N/A
N/A
52 Week Low
$5.29
$24.53
52 Week High
$26.95
$37.46

Technical Indicators

Market Signals
Indicator
CRVS
MCBS
Relative Strength Index (RSI) 51.49 47.73
Support Level $14.24 $35.06
Resistance Level $16.66 $37.06
Average True Range (ATR) 0.70 0.67
MACD -0.03 -0.08
Stochastic Oscillator 56.16 31.01

Price Performance

Historical Comparison
CRVS
MCBS

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

About MCBS MetroCity Bankshares Inc.

MetroCity Bankshares Inc is a bank holding company. Through its banking subsidiary, it operates as a full-service commercial bank focused on delivering various financial products and services to the small-to medium-sized businesses and individuals in its markets, including many customers in diverse and multi-ethnic communities in metropolitan markets in the Eastern U.S., Texas and California. The company provides commercial banking services such as consumer and commercial checking accounts, savings accounts, certificates of deposits, commercial and consumer loans, money transfers, and a variety of other banking services. The majority of its revenue is generated in the form of interest income.

Share on Social Networks: